{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:48:23Z","timestamp":1776984503112,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.mce.2005.03.016","type":"journal-article","created":{"date-parts":[[2005,5,27]],"date-time":"2005-05-27T11:02:16Z","timestamp":1117191736000},"page":"55-61","source":"Crossref","is-referenced-by-count":44,"title":["Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes"],"prefix":"10.1016","volume":"239","author":[{"given":"Tae-Yon","family":"Chun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Howard","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2005.03.016_bib1","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.mce.2005.03.016_bib2","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.HYP.32.6.965","article-title":"Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1","volume":"32","author":"Brown","year":"1998","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.mce.2005.03.016_bib3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1210\/jc.85.1.336","article-title":"Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production","volume":"85","author":"Brown","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.mce.2005.03.016_bib4","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","article-title":"Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo","volume":"58","author":"Brown","year":"2000","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.mce.2005.03.016_bib5","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1210\/jc.2003-031545","article-title":"Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes","volume":"89","author":"Calo","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.mce.2005.03.016_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0303-7207(02)00112-0","article-title":"Spironolactone increases integrin beta3 gene expression in kidney and heart muscle cells","volume":"194","author":"Chun","year":"2002","journal-title":"Mol. Cell Endocrinol."},{"issue":"5","key":"10.1016\/j.mce.2005.03.016_bib7","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/en.2002-220956","article-title":"Aldosterone inhibits inducible nitric oxide synthase in neonatal rat cardiomyocytes","volume":"144","author":"Chun","year":"2003","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.mce.2005.03.016_bib8","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.95.5.2325","article-title":"Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth","volume":"95","author":"Chun","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.mce.2005.03.016_bib9","doi-asserted-by":"crossref","first-page":"F209","DOI":"10.1152\/ajprenal.00032.2002","article-title":"Plasminogen activator inhibitor-1 and the kidney","volume":"283","author":"Eddy","year":"2002","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"11","key":"10.1016\/j.mce.2005.03.016_bib10","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1046\/j.1538-7836.2003.00437.x","article-title":"Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic mice","volume":"1","author":"Eren","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.mce.2005.03.016_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1006\/cimm.1993.1263","article-title":"Regulation of plasminogen activator inhibitor-1 levels in human monocytes","volume":"152","author":"Hamilton","year":"1993","journal-title":"Cell Immunol."},{"issue":"8549","key":"10.1016\/j.mce.2005.03.016_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(87)93050-9","article-title":"Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction","volume":"2","author":"Hamsten","year":"1987","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.mce.2005.03.016_bib13","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198512193132501","article-title":"Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction","volume":"313","author":"Hamsten","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.mce.2005.03.016_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/nar\/19.1.163","article-title":"Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor","volume":"19","author":"Hopkins","year":"1991","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.mce.2005.03.016_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/hc3301.092803","article-title":"Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition","volume":"104","author":"Kaikita","year":"2001","journal-title":"Circulation"},{"issue":"34","key":"10.1016\/j.mce.2005.03.016_bib16","doi-asserted-by":"crossref","first-page":"23048","DOI":"10.1016\/S0021-9258(18)54461-6","article-title":"Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta","volume":"266","author":"Keeton","year":"1991","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.mce.2005.03.016_bib17","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI11765","article-title":"PAI-1, fibrosis, and the elusive provisional fibrin matrix","volume":"106","author":"Loskutoff","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.mce.2005.03.016_bib18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/j.1460-2075.1987.tb02365.x","article-title":"Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts","volume":"6","author":"Lund","year":"1987","journal-title":"EMBO J."},{"issue":"20","key":"10.1016\/j.mce.2005.03.016_bib19","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.CIR.0000097000.51723.6F","article-title":"Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II\/NG-nitro-l-arginine methyl ester-induced myocardial injury","volume":"108","author":"Oestreicher","year":"2003","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.mce.2005.03.016_bib20","doi-asserted-by":"crossref","first-page":"11709","DOI":"10.1073\/pnas.95.20.11709","article-title":"Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells","volume":"95","author":"Olofsson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.mce.2005.03.016_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/hc0402.102929","article-title":"Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1","volume":"105","author":"Pahor","year":"2002","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.mce.2005.03.016_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2005.03.016_bib23","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2005.03.016_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure","volume":"93","author":"Qin","year":"2003","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.mce.2005.03.016_bib25","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/01.CIR.87.6.1969","article-title":"Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function","volume":"87","author":"Ridker","year":"1993","journal-title":"Circulation"},{"issue":"1 Pt 2","key":"10.1016\/j.mce.2005.03.016_bib26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","article-title":"Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats","volume":"31","author":"Rocha","year":"1998","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.mce.2005.03.016_bib27","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/en.141.10.3871","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.mce.2005.03.016_bib28","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1083\/jcb.105.2.957","article-title":"The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells","volume":"105","author":"Saksela","year":"1987","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mce.2005.03.016_bib29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.cb.04.110188.000521","article-title":"Cell-associated plasminogen activation: regulation and physiological functions","volume":"4","author":"Saksela","year":"1988","journal-title":"Annu. Rev. Cell Biol."},{"issue":"2","key":"10.1016\/j.mce.2005.03.016_bib30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1210\/jc.87.2.448","article-title":"Spironolactone abolishes the relationship between aldosterone and plasminogen activator inhibitor-1 in humans","volume":"87","author":"Sawathiparnich","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"15","key":"10.1016\/j.mce.2005.03.016_bib31","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1073\/pnas.89.15.6998","article-title":"Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries","volume":"89","author":"Schneiderman","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"15","key":"10.1016\/j.mce.2005.03.016_bib32","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1073\/pnas.85.15.5525","article-title":"Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter","volume":"85","author":"van Zonneveld","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.mce.2005.03.016_bib33","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1172\/JCI117809","article-title":"Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis","volume":"95","author":"Vaughan","year":"1995","journal-title":"J Clin. Invest."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720705001620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303720705001620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T02:30:17Z","timestamp":1625970617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303720705001620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":33,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0303720705001620"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2005.03.016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1027942.334890","asserted-by":"object"}]},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}